News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Backs Another Cambridge Biotech



7/3/2013 6:15:17 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca’s impact on the Cambridge medical technology cluster has gone up another notch with yet another deal involving a key player in the segment.

Having decided to bring its global HQ to the UK’s biomedical hotspot and following a string of deals with local companies, AZ has now backed Optibrium, a developer of software for drug discovery.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES